Skip to Content

← See all Senna-S brands

Senna-S by McKesson

Dosage form: tablet, coated
Ingredients: DOCUSATE SODIUM 50mg, SENNOSIDES 8.6mg
Labeler: McKesson
NDC Code: 62011-0161

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Health Mart Senna-S

Active ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

Stool softener

Stimulant laxative

Uses
  • relief of occasional constipation (irregularity).
  • generally causes bowel movement within 6 to 12 hours.

Warnings

Do not use

  • if you are now taking mineral oil, unless directed by a doctor
  •  laxative products for longer than 1 week, unless directed by a doctor

Ask a doctor before use if you have
  • stomach pain
  • nausea
  • vomiting
  • a sudden change in bowel habits that lasts over a period of 2 weeks

Stop use and ask a doctor if you haverectal bleeding or fail to have a bowel movement after the use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health care professional before use.


Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
  • taken preferably at bedtime or as directed by a doctor
Age
Starting Dose
Maximum Dosage
adults and children 12 years of age and older2 tablets once a day
4 tablets twice a day
children 6 to under 12 years of age1 tablet once a day
2 tablets twice a day
children 2 to 6 years of age1/2 tablet once a day
1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information
  • each tablet contains: sodium 6 mg/tablet LOW SODIUM
  • each tablet contains: calcium 20 mg/tablet
  • store at 15°-30°C (59°-86°F),in well closed containers
  • do not use if imprinted safety seal under cap is broken or missing
  • *This product is not manufactured or distributed by Purdue Pharma L.P., owner of the registered trademark Senokot S.

Inactive ingredientscarnauba wax, croscarmellose sodium, DandC Yellow 10 Aluminum Lake, dibasic calcium phosphate dihydrate, FDandC Blue 2 Aluminum Lake*, FDandC Red 40 Aluminum Lake*, FDandC Yellow 6 Aluminum Lake, hypromellose, magnesium stearate, maltodextrin*, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol*, purified water*, silicon dioxide, sodium benzoate, stearic acid, talc*, and titanium dioxide

*contains one or more of these ingredients

Product Labeling

NDC 62011-0161-1

Compare the  Senokot-S® active ingredients **

SENNA-S

Docusatee Sodium, 50 mg
Sennosides, 8.6 mg

Stool softener with laxative

60 TABLETS

McKesson

Another Quality Product

Distributed by McKesson
One Post Street, San Francisco, CA 94104
Money Back Guarantee
www.healthmart.com/healthmartbrand

SENNA-S 
docusate sodium, sennosides tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62011-0161
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CARNAUBA WAX 
CROSCARMELLOSE SODIUM 
D&C YELLOW NO. 10 
DIBASIC CALCIUM PHOSPHATE DIHYDRATE 
FD&C BLUE NO. 2 
FD&C RED NO. 40 
FD&C YELLOW NO. 6 
HYPROMELLOSES 
MAGNESIUM STEARATE 
MALTODEXTRIN 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOLS 
POLYVINYL ALCOHOL 
WATER 
SILICON DIOXIDE 
SODIUM BENZOATE 
STEARIC ACID 
TALC 
TITANIUM DIOXIDE 
Product Characteristics
ColororangeScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeSS1;S35;TCL081
Contains    
Packaging
#Item CodePackage Description
1NDC:62011-0161-11 BOTTLE, PLASTIC (BOTTLE) in 1 BOX
160 TABLET, COATED (TABLET) in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33405/18/2012
Labeler - McKesson (177667227)

 
McKesson

← See all Senna-S brands

Medically reviewed on May 18, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide